The role of human melanoma cell ICAM-1 expression on lymphokine activated killer cell-mediated lysis, and the effect of retinoic acid

British Journal of Cancer

Volumn 80, Issue 10, 1999, Pages 1494-1500

  Alexander, C L ^a   Edward, M ^a   MacKie, R M ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

ICAM 1; LAK cells; Melanoma; Retinoic acid

Indexed keywords

ANTIBODY; INTERCELLULAR ADHESION MOLECULE 1; RETINOIC ACID;

ARTICLE; CANCER CELL CULTURE; CHROMIUM 51 RELEASE; CONTROLLED STUDY; CYTOLYSIS; HUMAN; HUMAN CELL; LYMPHOKINE ACTIVATED KILLER CELL; MELANOMA CELL; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL DESTRUCTION;

ANTIBODIES; CELL SURVIVAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; KILLER CELLS, LYMPHOKINE-ACTIVATED; MELANOMA; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0032988150     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690551     Document Type: Article

References (37)

1. Altomonte M, Gloghini A, Bertola G, Gasparollo A, Carbone A, Ferrone S and Maio M (1993) Differential expression of cell adhesion molecules CD54/CDIIa and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells. Cancer Res 53: 3343-3348
2. Aoudjit F, Bousse M, Stratowa C, Voraberger G and Audette M (1994) Regulation of intercellular adhesion molecule-1 expression by retinoic acid: analysis of the 5′ regulatory region of the gene. Int J Cancer 58: 543-549
3. Babina M, Weber S and Henz BM (1997) Retinoic acids and dexamethasone alter cell surface density of β-2 integrins and ICAM-1 on human leukemic (HMC-1) mast cells. Arch Derm Res 289: 111-115
4. Banks RE, Gearing AJH, Hemingway IK, Norfolk DR, Perren TJ and Selby PJ (1993) Circulating ICAM-1, E-selectin and vascular cell adhesion molecule (VCAM) in human malignancies. Br J Cancer 68: 122-124
5. Bassi V, Vitale M, Feliciello A, Deriu S, Rossi G and Fenzi G (1995) Retinoic acid induces ICAM-1 hyperexpression in human thyroid carcinoma cell lines. J Clin Endocrinol Metabol 80: 1129-1135
6. Becker JC, Dummer R, Schmidt RE, Burg G and Hartmann AA (1992) Shedding of intercellular adhesion molecule-1 (ICAM-1) from melanoma cell lines -functional consequences on cell-mediated cytotoxicity. Immun Infect 20: 62-63
7. Bouillon M, Tessier P, Boulianne R, Destrempe R and Audette M (1991) Regulation by retinoic acid of ICAM-1 expression on human tumour cell lines. Biochim Biophys Acta 1097: 95-102
8. Budnik A, Grewe M, Gyufko K and Krutmann J (1996) Analysis of the production of soluble ICAM-1 molecules by human cells. Exp Hematol 24: 352-359
9. Cao XT, Chen GY, He L, Zhang WP, Yu YZ and Wang JL (1997) Involvement of MHC class 1 molecule and ICAM-1 in the enhancement of adhesion and cytotoxic susceptibility to immune effector cells transfected with the interleukin (IL)-2, IL-4 or IL-6 gene. J Cancer Res Clin Oncol 123: 602-608
10. Cilenti L, Toniato E, Ruggiero P, Fusco C, Farina AR, Tiberio A, Hatday AC, Gulino A, Frati L and Martinotti S (1995) Transcriptional modulation of the human intercellular adhesion molecule gene-1 (ICAM-1) by retinoic acid. Exp Cell Res 218: 263-270
11. Creasey AA, Smith HS, Hackett AJ, Fukuyama K, Epstein WL and Madin SH (1979) Biological properties of human melanoma cells in culture. In vitro Cell Dev Biol 15: 342-350
12. Eisenthal A, Marder O, Maymon B, Misonzhnik F, Skornick Y, Brazowski E, Czernobilsky B, Walt H and Lifschitz-Mercer B (1998) The effect of interferon gamma and tumour necrosis factor alpha on the expression of ICAM-1 and HLA-DR molecules on cells of a human germ cell neoplasm and their susceptibility to lysis by lymphokine-activated killer cells. Pathobiology 66: 205-208
13. Gao Z and MacKenzie IC (1996) Influence of retinoic acid on the expression of cytokeratins, vimentin and ICAM-1 in human gingival epithelia in-vitro. J Peridont Res 31: 81-89
14. Giavazzi R, Chirivi RGS, Garofalo A, Rambaldi A, Hemingway I, Pigott R and Gearing AJH (1992) Soluble intercellular adhesion molecule-1 is released by human melanoma cells and is associated with tumour growth in nude mice. Cancer Res 52: 2628-2630
15. Gwin JL, Taylor CG, Taylor DD and Eisenberg B (1996) Role of LFA-3, ICAM-1 and MHC class I on the sensitivity of human tumour cells to LAK cells. J Surg Res 60: 129-136
16. Harning R, Mainolfi E, Bystryn JC, Henn M, Merluzzi VJ and Rothlein R (1991) Serum levels of circulating ICAM-1 in human malignant melanoma. Cancer Res 51: 5003-5005
17. Heymann D, Godard A, Raher S, Ringeard S, Lassort D, Blanchard F and Harb J (1995) Human interleukin for DA cells leukemia inhibitory factor and oncostatin-M enhance membrane expression of intercellular adhesion molecule-1 on melanoma cell but not the shedding of its soluble form. Cytokine 7: 111-117
18. Ishiwata N, Takio K, Katayama H, Watanabe K, Titani K, Ikeda Y and Handa M (1994) An alternatively spliced isoform of P-selectin is present in vivo as a soluble molecule. J Biol Chem 269: 23708-23715
19. Jackson AM, Alexandrov AB, Prescott S, James K and Chisholm GD (1992) Role of adhesion molecules in lymphokine-activated killer cell killing of bladder cancer cells: further evidence for a third ligand for leukocyte function associated antigen-1. Immunology 76: 286-291
20. Jackson AM, Alexandrov AB, Gribben SC, Esuvarnathan K and James K (1993) Expression and shedding of ICAM-1 in bladder cancer cells and its role in immunotherapy. Int J Cancer 55: 921-925
21. Johnson JP, Stade BG, Holzmann B, Schwable W and Riethmuller G (1989) De novo expression of ICAM-1 in melanoma correlates with increased risk of metastasis. Proc Natl Acad Sci USA 86: 641-644
22. Kageshita T, Yoshii A, Kimura T, Kuriya N, Ono T, Tsujisaki M, Imai K and Ferrone S (1993) Clinical relevance of ICAM-1 expression in primary lesions and serum of patients with malignant melanoma. Cancer Res 53: 4927-4932
23. Kaufman DS (1995) Inhibition of selective signalling events in natural killer cells recognising MHC class 1. Proc Natl Acad Sci (USA) 92: 6484-6488
24. Lefor AT and Fabian DF (1998) Enhanced cytolytic activity of tumour infiltrating lymphocytes (TILs) derived from an ICAM-1 transfected tumour in a murine model. J Surg Res 75: 49-53
25. Maio M, Tessitori G, Pinto A, Temponi M, Colombatti A and Ferrone S (1989) Differential role of distinct determinants of ICAM-1 in immunologic phenomena. J Immunol 143: 181-188
26. Marlin SD and Springer TA (1987) Purified intercellular adhesion molecule-1 (ICAM-1 ) is a ligand for lymphocyte function associated antigen (LFA-1). Cell 51: 813-819
27. Pandolfi F, Trentin L, Boyle LA, Stamenkovie I, Byres HR, Colvin RB and Kurnick TJ (1992) Expression of cell adhesion molecules in human melanoma cell lines and their role in cytotoxicity mediated by tumour infiltrating lymphocytes. Cancer 69: 1165-1173
28. Rothlein RM, Czajkowski MM, O'Neili SD, Marlin E, Mainolfi EA and Merluzzi VJ (1988) Induction of intercellular adhesion molecule-1 on primary and continuous cell lines by pro-inflammatory cytokines. Regulation by pharmacologic agents and neutralizing antibodies. J Immunol 141: 1665-1669
29. Rothlein RM, Mainolfi EA, Czajkowski M and Marlin SD (1991) A form of circulating ICAM-1 in human serum. J Immunol 147: 3788-3793
30. Sanchez-Rovira P, Jimenez E, Carracedo J, Barneto IC, Ramirez R and Aranda E (1998) Serum levels of intercellular adhesion molecule 1 (ICAM-1) in patients with colorectal cancer: inhibitory effect on cytotoxicity. Eur J Cancer 34: 394-398
31. Smith MA, Parkinson DR, Cheson BD and Friedman MA (1992) Retinoids in cancer therapy. J Clin Oncol 10: 839-864
32. Staunton DE, Marlin SD, Stratowa C, Dustin ML and Springer TA (1988) Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 52: 925-933
33. Vanky F, Wang P, Patarroyo M and Klein E (1990) Expression of adhesion molecule ICAM-1 and MHC class 1 antigens on human tumour cells is required for their interaction with autologous lymphocytes in vitro. Cancer Immunol Immunother 31: 19-27
34. Wang ZG, Cao Y, Durso CM and Ferrone S (1992) Differential susceptibility of cultured human melanoma cell lines to enhancement by retinoic acid of intercellular adhesion molecule-1 expression. Cancer Res 52: 4766-4772
35. Webb DSA, Mostowski HS and Gerrard TL (1991) Cytokine induced enhancement of ICAM-1 expression results in increased vulnerability of tumour cells to monocyte mediated lysis. J Immunol 146: 3682-3686
36. Welch DR, Bisi JE, Miller BE, Conaway D, Seftor EA and Yohem KH (1991) Characterisation of a highly invasive and spontaneously metastatic human malignant melanoma cell line. Int J Cancer 47: 227-237
37. Young DG, Jackson AM and James K (1997) Purification and characterisation of soluble intercellular adhesion molecule-1 (sICAM-1) and its effect on cell mediated cytolysis of tumour cells. Int J Oncol 10: 827-834